Posted October 22, 2012
By Bloomberg
GSK using Nobel Prize winner's stem cells in drug research
Post a comment
Print this storyE-mail story
Share
Research Triangle Park, N.C. —
The breakthrough in stem cell research by a Nobel Prize winner has enabled GSK to create heart-muscle stem cells that may be used to test compounds for cardiovascular safety, says Jason Gardner, head of Glaxo's early-stage regenerative medicine research.Copyright 2013 Bloomberg. All rights reserved.
Please Log In to add a comment.





